Extractables from filter components in model solvent streams for pharmaceutical filtration processes.
Drug manufacturers use filters widely in their manufacturing processes for bioburden reduction and sterility assurance. In implementing a pharmaceutical filtration, it is essential to determine and profile the filter extractables that could be introduced into the product. There is an ongoing industry effort to explore the analysis of extractables. Toward this end, the use of complementary analytical techniques was evaluated to aid in extractables identification by determining whether the analysis of filters in the form of components, rather than entire assemblies, facilitated the profiling of extractables. The study examines filter components of 10-inch, 0.22-microm Durapore cartridge filters using Fourier transform infra-red spectroscopy (FTIR) and nuclear magnetic resonance spectroscopy (NMR), as well as determines the non-volatile residues (NVR) and total organic carbon contents (TOC) of the extractables. The complementary techniques of high performance liquid chromatography (HPLC/UV) and liquid chromatography nuclear magnetic resonance spectroscopy (LC/NMR) were also used. The results of the tests indicated very low levels of extractables.
Jiang
Tongbo
T
Millipore Corporation, 900 Middlesex Turnpike, Billerica, MA 01821, USA. tongbo_jiang@millipore.com
Phelan
Maurice
M
D002626:Chemistry, Pharmaceutical / Q000379:methods*; D005374:Filtration / Q000379:methods*; D009682:Magnetic Resonance Spectroscopy; D012015:Reference Standards; D012997:Solvents / Q000032:analysis*; D017550:Spectroscopy, Fourier Transform Infrared; D013678:Technology, Pharmaceutical / Q000295:instrumentation*
D012997:Solvents